Rigel Pharmaceuticals RIGL Deferred Tax Liabilities, Other
Deferred Tax Liabilities, Other at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxLiabilitiesOther.
The official record: Rigel Pharmaceuticals’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's deferred tax liabilities, other.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's deferred tax liabilities, other?
- Rigel Pharmaceuticals (RIGL) reported deferred tax liabilities, other of $327K in Q4 2025.